Intuitive Surgical Management

Management criteria checks 2/4

Intuitive Surgical's CEO is Gary Guthart, appointed in Jan 2010, has a tenure of 14.33 years. total yearly compensation is $12.45M, comprised of 7.7% salary and 92.3% bonuses, including company stock and options. directly owns 0.36% of the company’s shares, worth $472.06M. The average tenure of the management team and the board of directors is 3.3 years and 7.1 years respectively.

Key information

Gary Guthart

Chief executive officer

US$12.4m

Total compensation

CEO salary percentage	7.7%
CEO tenure	14.3yrs
CEO ownership	0.4%
Management average tenure	3.3yrs
Board average tenure	7.1yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Gary Guthart's remuneration changed compared to Intuitive Surgical's earnings?
Date	Total Compensation	Salary	Company Earnings
Mar 31 2024	n/a	n/a	US$2b
Dec 31 2023	US$12m	US$955k	US$2b
Sep 30 2023	n/a	n/a	US$2b
Jun 30 2023	n/a	n/a	US$1b
Mar 31 2023	n/a	n/a	US$1b
Dec 31 2022	US$10m	US$873k	US$1b
Sep 30 2022	n/a	n/a	US$1b
Jun 30 2022	n/a	n/a	US$1b
Mar 31 2022	n/a	n/a	US$2b
Dec 31 2021	US$8m	US$846k	US$2b
Sep 30 2021	n/a	n/a	US$2b
Jun 30 2021	n/a	n/a	US$2b
Mar 31 2021	n/a	n/a	US$1b
Dec 31 2020	US$6m	US$821k	US$1b
Sep 30 2020	n/a	n/a	US$1b
Jun 30 2020	n/a	n/a	US$1b
Mar 31 2020	n/a	n/a	US$1b
Dec 31 2019	US$6m	US$790k	US$1b
Sep 30 2019	n/a	n/a	US$1b
Jun 30 2019	n/a	n/a	US$1b
Mar 31 2019	n/a	n/a	US$1b
Dec 31 2018	US$6m	US$767k	US$1b
Sep 30 2018	n/a	n/a	US$804m
Jun 30 2018	n/a	n/a	US$810m
Mar 31 2018	n/a	n/a	US$778m
Dec 31 2017	US$5m	US$744k	US$671m

Compensation vs Market: Gary's total compensation ($USD12.45M) is above average for companies of similar size in the UK market ($USD5.62M).

Compensation vs Earnings: Gary's compensation has increased by more than 20% in the past year.

CEO

Gary Guthart (57 yo)

14.3yrs

Tenure

US$12,449,381

Compensation

Dr. Gary S. Guthart, Ph.D. has been Chief Executive Officer of Intuitive Surgical, Inc. since January 1, 2010 and was its President since July 12, 2007. Dr. Guthart served as the Chief Operating Officer at...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Gary Guthart	CEO & Director	14.3yrs	US$12.45m	0.36% $ 472.1m
David Rosa	President	less than a year	US$12.56m	0.061% $ 80.7m
Jamie Samath	Senior VP & CFO	2.3yrs	US$5.03m	0.0025% $ 3.2m
Henry Charlton	Senior VP & Chief Commercial and Marketing Officer	less than a year	US$5.10m	0.0066% $ 8.7m
Robert DeSantis	Executive VP and Chief Strategy & Corporate Operations Officer	8.5yrs	US$4.84m	0.0015% $ 2.0m
Fredrik Widman	VP, Principal Accounting Officer & Corporate Controller	4.3yrs	no data	0.000030% $ 39.4k
Gary Loeb	Senior VP	1.7yrs	no data	0.00053% $ 696.7k
Christopher Carlson	Executive Vice President of Research	less than a year	no data	no data
Marshall Mohr	Executive Vice President of Global Business Services	2.3yrs	US$4.44m	0.042% $ 55.5m
Myriam J. McAdams	Executive VP & Chief Medical Officer	10.3yrs	US$4.48m	0.000080% $ 105.2k
Brian Miller	Executive VP & Chief Digital Officer	8.9yrs	no data	0.0034% $ 4.5m
Glenn Vavoso	Senior VP & GM of APAC	9.3yrs	no data	no data

3.3yrs

Average Tenure

56yo

Average Age

Experienced Management: 0R29's management team is considered experienced (3.3 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Gary Guthart	CEO & Director	15.1yrs	US$12.45m	0.36% $ 472.1m
Amal Johnson	Independent Director	14.1yrs	US$388.12k	0.0035% $ 4.5m
Joseph Beery	Independent Director	4.1yrs	US$379.79k	0.00067% $ 880.8k
Craig Barratt	Independent Chairman	13.1yrs	US$498.74k	0.0074% $ 9.7m
Lewis Chew	Director	less than a year	no data	0.000010% $ 13.1k
Jami K. Nachtsheim	Independent Director	7.1yrs	US$383.12k	0.0016% $ 2.1m
Keith Leonard	Independent Director	8.3yrs	US$379.79k	0.00045% $ 591.6k
Amy Ladd	Independent Director	4.8yrs	US$376.79k	0.00036% $ 473.3k
Mark Rubash	Independent Director	16.6yrs	US$392.46k	0.0045% $ 6.0m
Monica Reed	Independent Director	3.1yrs	US$376.79k	0.00045% $ 591.6k
Sreelakshmi Kolli	Independent Director	less than a year	US$142.84k	0.000070% $ 92.0k

7.1yrs

Average Tenure

61yo

Average Age

Experienced Board: 0R29's board of directors are considered experienced (7.1 years average tenure).

Intuitive Surgical Management

Management criteria checks 2/4

Key information

Recent management updates

Intuitive Elects Lewis Chew as Board of Directors

Intuitive Surgical, Inc., Annual General Meeting, Apr 25, 2024

Intuitive Surgical, Inc. Appoints Sreelakshmi Kolli to Its Board of Directors

Intuitive Surgical, Inc. Announces Executive Changes

Insufficient new directors

Intuitive Surgical, Inc., Annual General Meeting, Apr 28, 2022

Recent updates

Intuitive Elects Lewis Chew as Board of Directors

First quarter 2024 earnings released: EPS: US$1.54 (vs US$1.02 in 1Q 2023)

Intuitive Surgical, Inc., Annual General Meeting, Apr 25, 2024

Intuitive Surgical, Inc. Announces FDA Clearance of Fifth-Generation Robotic System, Da Vinci 5

Full year 2023 earnings released: EPS: US$5.12 (vs US$3.72 in FY 2022)

Intuitive Surgical, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year of 2023

Intuitive Surgical, Inc. Appoints Sreelakshmi Kolli to Its Board of Directors

Third quarter 2023 earnings released: EPS: US$1.18 (vs US$0.91 in 3Q 2022)

Second quarter 2023 earnings released: EPS: US$1.20 (vs US$0.86 in 2Q 2022)

Intuitive Surgical, Inc.(NasdaqGS:ISRG) dropped from Russell 1000 Value Index

Intuitive Surgical, Inc. Announces Executive Changes

Insufficient new directors

First quarter 2023 earnings released: EPS: US$1.02 (vs US$1.02 in 1Q 2022)

Full year 2022 earnings released: EPS: US$3.72 (vs US$4.79 in FY 2021)

Intuitive Surgical, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year 2022

Third quarter 2022 earnings released: EPS: US$0.91 (vs US$1.07 in 3Q 2021)

Now 20% undervalued

Now 21% undervalued after recent price drop

Second quarter 2022 earnings released: EPS: US$0.86 (vs US$1.45 in 2Q 2021)

Now 21% undervalued after recent price drop

First quarter 2022 earnings released: EPS: US$1.02 (vs US$1.20 in 1Q 2021)

First quarter 2022 earnings released: EPS: US$1.02 (vs US$1.20 in 1Q 2021)

Intuitive Surgical, Inc., Annual General Meeting, Apr 28, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Intuitive Receives FDA Clearance for 8 mm SureForm 30 Curved-Tip Stapler

Third quarter 2021 earnings released: EPS US$2.17 (vs US$0.89 in 3Q 2020)

Second quarter 2021 earnings released: EPS US$4.36 (vs US$0.58 in 2Q 2020)

First quarter 2021 earnings released: EPS US$3.61 (vs US$2.69 in 1Q 2020)

New 90-day low: US$725

Full year 2020 earnings released: EPS US$9.07 (vs US$11.95 in FY 2019)

Revenue beats expectations

Full year 2020 earnings released: EPS US$9.07

Revenue beats expectations

Intuitive Surgical, Inc. to Report Q4, 2020 Results on Jan 21, 2021

New 90-day high: US$804

New 90-day low: US$463

Market pulls back on stock over the past week

New 90-day low: US$463

Third quarter earnings released

Third-quarter earnings released: Revenue beats expectations

New 90-day high: US$750

New 90-day high - US$700

New 90-day high - US$686

New 90-day high - US$638

CEO Compensation Analysis

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age